About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [1,371 citations: 1–100 of 1,208 articles]

Articles published in Parkinson’s Disease have been cited 1,371 times. The following is a list of the 1,208 articles that have cited the articles published in Parkinson’s Disease.

  • Marianne Amalric, “Targeting metabotropic glutamate receptors (mGluRs) in Parkinson's disease,” Current Opinion in Pharmacology, vol. 20, pp. 29–34, 2015. View at Publisher · View at Google Scholar
  • Gyan P Modi, Chandrashekhar Voshavar, Sanjib Gogoi, Mrudang Shah, Tamara Antonio, Maarten E. A. Reith, and Aloke K. Dutta, “Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: Modulator of toxicity of Alpha synuclein aggregates,” ACS Chemical Neuroscience, pp. 140624131824004, 2014. View at Publisher · View at Google Scholar
  • M. A. Hobert, W. Maetzler, K. Aminian, and L. Chiari, “Technical and clinical view on ambulatory assessment in Parkinson's disease,” Acta Neurologica Scandinavica, vol. 130, no. 3, pp. 139–147, 2014. View at Publisher · View at Google Scholar
  • Veronica Bisagno, and Christopher Mark Milroy, “Neuropathology of substance use disorders,” Acta Neuropathologica, vol. 127, no. 1, pp. 91–107, 2014. View at Publisher · View at Google Scholar
  • Silke Nuber, Daniel Tadros, Jerel Fields, Cassia Rose Overk, Benjamin Ettle, Kori Kosberg, Michael Mante, Edward Rockenstein, Margarita Trejo, and Eliezer Masliah, “Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD,” Acta Neuropathologica, vol. 127, no. 4, pp. 477–494, 2014. View at Publisher · View at Google Scholar
  • Md Sarwar Jahan, Mohd Nozulaidi, Mohammad Moneruzzaman Khandaker, Ainun Afifah, and Nurul Husna, “Control of plant growth and water loss by a lack of light-harvesting complexes in photosystem II in Arabidopsis thaliana ch1-1 mutant,” Acta Physiologiae Plantarum, vol. 36, no. 7, pp. 1627–1635, 2014. View at Publisher · View at Google Scholar
  • Hao Deng, and Lamei Yuan, “Genetic variants and animal models in SNCA and Parkinson disease,” Ageing Research Reviews, 2014. View at Publisher · View at Google Scholar
  • Nancy Monroy-Jaramillo, Jorge Luis Guerrero-Camacho, Mayela Rodríguez-Violante, Marie-Catherine Boll-Woehrlen, Petra Yescas-Gómez, María Elisa Alonso-Vilatela, and Marisol López-López, “Genetic mutations in early-onset Parkinson's disease Mexican patients: Molecular testing implications,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2014. View at Publisher · View at Google Scholar
  • Sherrilene Classen, Babette Brumback, Miriam Monahan, Irene I. Malaty, Ramon L. Rodriguez, Michael S. Okun, and Nikolaus R. McFarland, “Driving Errors in Parkinson's Disease: Moving Closer to Predicting On-Road Outcomes,” American Journal of Occupational Therapy, vol. 68, no. 1, pp. 77–85, 2014. View at Publisher · View at Google Scholar
  • Benjamin J. Kim, Gui-Shuang Ying, Jiayan Huang, Nicole E. Levy, and Maureen G. Maguire, “Sporadic Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT),” American Journal of Ophthalmology, vol. 158, no. 1, pp. 128–135, 2014. View at Publisher · View at Google Scholar
  • Gavin Williams, Michelle Kahn, and Alana Randall, “Strength Training for Walking in Neurologic Rehabilitation Is Not Task Specific A Focused Review,” American Journal of Physical Medicine & Rehabilitation, vol. 93, no. 6, pp. 511–522, 2014. View at Publisher · View at Google Scholar
  • B. R. Amar, Ravi Yadav, Y. C. Janardhan Reddy, and Pramod Kumar Pal, “A clinical profile of patients with Parkinson's disease and psychosis,” Annals of Indian Academy of Neurology, vol. 17, no. 2, pp. 187–192, 2014. View at Publisher · View at Google Scholar
  • Sarah A. Eisenstein, Jonathan M. Koller, Kathleen D. Black, Meghan C. Campbell, Heather M. Lugar, Mwiza Ushe, Samer D. Tabbal, Morvarid Karimi, Tamara Hershey, Joel S. Perlmutter, and Kevin J. Black, “Functional Anatomy of Subthalamic Nucleus Stimulation in Parkinson Disease,” Annals of Neurology, vol. 76, no. 2, pp. 279–295, 2014. View at Publisher · View at Google Scholar
  • Nigel H. Greig, Kumar Sambamurti, Debomoy K. Lahiri, and Robert E. Becker, “Amyloid-beta Precursor Protein Synthesis Inhibitors for Alzheimer's Disease Treatment,” Annals of Neurology, vol. 76, no. 4, pp. 629–630, 2014. View at Publisher · View at Google Scholar
  • Neena Singh, Swati Haldar, Ajai K. Tripathi, Katharine Horback, Joseph Wong, Deepak Sharma, Amber Beserra, Srinivas Suda, Charumathi Anbalagan, Som Dev, Chinmay K. Mukhopadhyay, and Ajay Singh, “Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities,” Antioxidants & Redox Signaling, vol. 20, no. 8, pp. 1324–1363, 2014. View at Publisher · View at Google Scholar
  • Paraskevi Kourtidou, Dimitrios Kasselimis, Constantin Potagas, Ioannis Zalonis, and Ioannis Evdokimidis, “Dissociating Between the Effects of Mental Flexibility and Motor Dysfunction on Cognitive Performance in Patients With Parkinson's Disease,” Archives of Neuroscience, vol. 2, no. 3, 2014. View at Publisher · View at Google Scholar
  • Elizabeth L. Stegemoeller, Joe Nocera, Irene Malaty, Mack Shelley, Michael. S. Okun, and Chris J. Hass, “Timed Up and Go, Cognitive, and Quality-of-Life Correlates in Parkinson's Disease,” Archives of Physical Medicine and Rehabilitation, vol. 95, no. 4, pp. 649–655, 2014. View at Publisher · View at Google Scholar
  • Francesco Cordici, Carmelo Genovese, and Placido Bramanti, “Choline Associated Hypersexuality in a 79-Year-Old Man,” Archives of Sexual Behavior, vol. 43, no. 1, pp. 187–189, 2014. View at Publisher · View at Google Scholar
  • Jasvinder A. Singh, “Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study,” Arthritis Research & Therapy, vol. 16, no. 2, 2014. View at Publisher · View at Google Scholar
  • Soumyabrata Munshi, Vineet Kumar Khemka, Kalpita Banerjee, and Sasanka Chakrabarti, “Clinicotherapeutic Potential of Leptin in Alzheimer’s Disease and Parkinson’s Disease,” Asian Journal of Neuroscience, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Lay Khoon Too, James A. McQuillan, Helen J. Ball, Masaaki Kanai, Toshikazu Nakamura, Hiroshi Funakoshi, Iain S. McGregor, and Nicholas H. Hunt, “The kynurenine pathway contributes to long-term neuropsychological changes in experimental pneumococcal meningitis,” Behavioural Brain Research, vol. 270, pp. 179–195, 2014. View at Publisher · View at Google Scholar
  • Janaina K. Barbiero, Ronise M. Santiago, Daniele Suzete Persike, Maria Jose da Silva Fernandes, Fernanda S. Tonin, Claudio da Cunha, Suelen Lucio Boschen, Marcelo M. S. Lima, and Maria A. B. F. Vital, “Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine,” Behavioural Brain Research, vol. 274, pp. 390–399, 2014. View at Publisher · View at Google Scholar
  • Weidong Pan, Yu Song, Shin Kwak, Sohei Yoshida, and Yoshiharu Yamamoto, “Quantitative Evaluation of the Use of Actigraphy for Neurological and Psychiatric Disorders,” Behavioural Neurology, vol. 2014, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Alberto Costa, Antonella Peppe, Ilenia Mazzù, Mariachiara Longarzo, Carlo Caltagirone, and Giovanni A. Carlesimo, “Dopamine Treatment and Cognitive Functioning in Individuals with Parkinson’s Disease: The “Cognitive Flexibility” Hypothesis Seems to Work,” Behavioural Neurology, vol. 2014, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • Sanghamitra Bandyopadhyay, and Jack T. Rogers, “Azheimer's Disease Therapeutics Targeted to the Control of Amyloid Precursor Protein Translation: Maintenance of Brain Iron Homeostasis,” Biochemical Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Dezerae Cox, John A. Carver, and Heath Ecroyd, “Preventing α-synuclein aggregation: The role of the small heat-shock molecular chaperone proteins,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014. View at Publisher · View at Google Scholar
  • Mark D. Turner, Belinda Nedjai, Tara Hurst, and Daniel J. Pennington, “Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014. View at Publisher · View at Google Scholar
  • Dmytro V. Gospodaryov, Oleh V. Lushchak, Bohdana M. Rovenko, Natalia V. Perkhulyn, Mike Gerards, Tea Tuomela, and Howard T. Jacobs, “Ciona intestinalis NADH dehydrogenase NDX confers stress-resistance and extended lifespan on Drosophila,” Biochimica et Biophysica Acta-Bioenergetics, vol. 1837, no. 11, pp. 1861–1869, 2014. View at Publisher · View at Google Scholar
  • Manish Verma, Erin K. Steer, and Charleen T. Chu, “ERKed by LRRK2: A cell biological perspective on hereditary and sporadic Parkinson's disease,” Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1842, no. 8, pp. 1273–1281, 2014. View at Publisher · View at Google Scholar
  • Mary Dawn Hennessy, Rochelle S. Zak, Caryl L. Gay, Clive R. Pullinger, Kathryn A. Lee, and Bradley E. Aouizerat, “Polymorphisms of Interleukin-1 Beta and Interleukin-17Alpha Genes Are Associated With Restless Legs Syndrome,” Biological Research for Nursing, vol. 16, no. 2, pp. 143–151, 2014. View at Publisher · View at Google Scholar
  • Yoon-Sang Oh, Joong-Seok Kim, Yeong-In Kim, Dong-Won Yang, Ja-Seong Koo, Hae Ok Jung, and Kwang-Soo Lee, “Circadian blood pressure and heart rate variations in de novo Parkinson's disease,” Biological Rhythm Research, vol. 45, no. 3, pp. 335–343, 2014. View at Publisher · View at Google Scholar
  • D. Galeano, F. Brunetti, D. Torricelli, S. Piazza, and J. L. Pons, “A Tool for Balance Control Training Using Muscle Synergies and Multimodal Interfaces,” BioMed Research International, vol. 2014, pp. 1–13, 2014. View at Publisher · View at Google Scholar
  • Wei-Che Lin, Nai-Wen Tsai, Yung-Cheng Huang, Kuei-Yueh Cheng, Hsiu-Ling Chen, Shau-Hsuan Li, Chia-Te Kung, Yu-Jih Su, Wei-Ming Lin, Meng-Hsiang Chen, Tsui-Min Chiu, I-Hsiao Yang, and Cheng-Hsien Lu, “Peripheral Leukocyte Apoptosis in Patients with Parkinsonism: Correlation with Clinical Characteristics and Neuroimaging Findings,” BioMed Research International, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Yinxia Chao, Siew Cheng Wong, and Eng King Tan, “Evidence of Inflammatory System Involvement in Parkinson’s Disease,” BioMed Research International, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Yasir Hasan Siddique, Falaq Naz, and Smita Jyoti, “Effect of Curcumin on Lifespan, Activity Pattern, Oxidative Stress, and Apoptosis in the Brains of Transgenic Drosophila Model of Parkinson’s Disease,” BioMed Research International, vol. 2014, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Joachim D. Uys, Patrick J. Mulholland, and Danyelle M. Townsend, “Glutathione and redox signaling in substance abuse,” Biomedicine & Pharmacotherapy, 2014. View at Publisher · View at Google Scholar
  • In Su Kim, and Jin Hwan Do, “Signaling pathway analysis of MPP+-treated human neuroblastoma SH-SY5Y cells,” Biotechnology and Bioprocess Engineering, vol. 19, no. 2, pp. 332–340, 2014. View at Publisher · View at Google Scholar
  • Stina B. Jonasson, Maria H. Nilsson, and Jan Lexell, “Psychometric properties of four fear of falling rating scales in people with Parkinson's disease,” Bmc Geriatrics, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Beata Lindholm, Peter Hagell, Oskar Hansson, and Maria H Nilsson, “Factors associated with fear of falling in people with Parkinson’s disease,” BMC Neurology, vol. 14, no. 1, pp. 19, 2014. View at Publisher · View at Google Scholar
  • Carolien Strouwen, Esther A. L. M. Molenaar, Samyra H. J. Keus, Liesbeth Munks, Marten Munneke, Wim Vandenberghe, Bastiaan R. Bloem, and Alice Nieuwboer, “Protocol for a randomized comparison of integrated versus consecutive dual task practice in Parkinson's disease: the DUALITY trial,” Bmc Neurology, vol. 14, 2014. View at Publisher · View at Google Scholar
  • Mary Danoudis, and Robert Iansek, “Gait in Huntington's disease and the stride length-cadence relationship,” Bmc Neurology, vol. 14, 2014. View at Publisher · View at Google Scholar
  • L. Christopher, Y. Koshimori, A. E. Lang, M. Criaud, and A. P. Strafella, “Uncovering the role of the insula in non-motor symptoms of Parkinson's disease,” Brain, 2014. View at Publisher · View at Google Scholar
  • Kenichiro Tanaka, Kenji Wada-Isoe, Mikie Yamamoto, Shugo Tagashira, Yuki Tajiri, Satoko Nakashita, and Kenji Nakashima, “Clinical evaluation of fatigue in Japanese patients with Parkinson's disease,” Brain and Behavior, 2014. View at Publisher · View at Google Scholar
  • Felicitas Ehlen, Thomas Schoenecker, Andrea A. Kühn, and Fabian Klostermann, “Differential effects of deep brain stimulation on verbal fluency,” Brain and Language, vol. 134, pp. 23–33, 2014. View at Publisher · View at Google Scholar
  • Eva M. Müller-Oehring, Edith V. Sullivan, Adolf Pfefferbaum, Neng C. Huang, Kathleen L. Poston, Helen M. Bronte-Stewart, and Tilman Schulte, “Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson’s disease,” Brain Imaging and Behavior, 2014. View at Publisher · View at Google Scholar
  • Hooman Ganjavi, D. Louis Collins, Alan C. Evans, and Sherif Karama, “Investigating the relation between striatal volume and IQ,” Brain Imaging and Behavior, vol. 8, no. 1, pp. 52–59, 2014. View at Publisher · View at Google Scholar
  • Simon Ketteler, Daniel Ketteler, René Vohn, Frank Kastrau, Jörg B. Schulz, Kathrin Reetz, and Walter Huber, “The processing of lexical ambiguity in healthy ageing and Parkinson׳s disease: Role of cortico-subcortical networks,” Brain Research, 2014. View at Publisher · View at Google Scholar
  • Scott J. Varga, Cheng Qi, Eric Podolsky, and Daewoo Lee, “A new Drosophila model to study the interaction between genetic and environmental factors in Parkinson's disease,” Brain Research, vol. 1583, pp. 277–286, 2014. View at Publisher · View at Google Scholar
  • Sarah A. Eisenstein, William B. Dewispelaere, Meghan C. Campbell, Heather M. Lugar, Joel S. Perlmutter, Kevin J. Black, and Tamara Hershey, “Acute Changes in Mood Induced by Subthalamic Deep Brain Stimulation in Parkinson Disease Are Modulated by Psychiatric Diagnosis,” Brain Stimulation, vol. 7, no. 5, pp. 701–708, 2014. View at Publisher · View at Google Scholar
  • Isabel Ubeda-Banon, Daniel Saiz-Sanchez, Carlos de la Rosa-Prieto, and Alino Martinez-Marcos, “alpha-Synuclein in the olfactory system in Parkinson's disease: role of neural connections on spreading pathology,” Brain Structure & Function, vol. 219, no. 5, pp. 1513–1526, 2014. View at Publisher · View at Google Scholar
  • Claudia Diana Wurster, Heiko Graf, Hermann Ackermann, Katharina Groth, Jan Kassubek, and Axel Riecker, “Neural correlates of rate-dependent finger-tapping in Parkinson’s disease,” Brain Structure and Function, 2014. View at Publisher · View at Google Scholar
  • Zhuan Hong, Xiang Cao, Na Li, Yizhou Zhang, Lei Lan, Yi Zhou, Xiaolong Pan, Lei Shen, Zhimin Yin, and Lan Luo, “Luteolin is effective in the non-small cell lung cancer model with L858R/T790M EGF receptor mutation and erlotinib resistance,” British Journal of Pharmacology, vol. 171, no. 11, pp. 2842–2853, 2014. View at Publisher · View at Google Scholar
  • Durdane Aksoy, Huseyin Ortak, Semiha Kurt, Emre Cevik, and Betul Cevik, “Central corneal thickness and its relationship to Parkinson’s disease severity,” Canadian Journal of Ophthalmology / Journal Canadien d'Ophtalmologie, vol. 49, no. 2, pp. 152–156, 2014. View at Publisher · View at Google Scholar
  • L. F. Burbulla, J. C. Fitzgerald, K. Stegen, J. Westermeier, A-K Thost, H. Kato, D. Mokranjac, J. Sauerwald, L. M. Martins, D. Woitalla, D. Rapaport, O. Riess, T. Proikas-Cezanne, T. M. Rasse, and R. Krueger, “Mitochondrial proteolytic stress induced by loss of mortalin function is rescued by Parkin and PINK1,” Cell Death & Disease, vol. 5, 2014. View at Publisher · View at Google Scholar
  • S. Yang, C. Xia, S. Li, L. Du, L. Zhang, and Y. Hu, “Mitochondrial dysfunction driven by the LRRK2-mediated pathway is associated with loss of Purkinje cells and motor coordination deficits in diabetic rat model,” Cell Death & Disease, vol. 5, 2014. View at Publisher · View at Google Scholar
  • S. Saez-Atienzar, L. Bonet-Ponce, J. R. Blesa, F. J. Romero, M. P. Murphy, J. Jordan, and M. F. Galindo, “The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling,” Cell Death & Disease, vol. 5, 2014. View at Publisher · View at Google Scholar
  • David P. Marciano, Mi Ra Chang, Cesar A. Corzo, Devrishi Goswami, Vinh Q. Lam, Bruce D. Pascal, and Patrick R. Griffin, “The Therapeutic Potential of Nuclear Receptor Modulators for Treatment of Metabolic Disorders: PPARγ, RORs, and Rev-erbs,” Cell Metabolism, 2014. View at Publisher · View at Google Scholar
  • Adelaide Fernandes, Leonor Miller-Fleming, and Teresa F. Pais, “Microglia and inflammation: conspiracy, controversy or control?,” Cellular and Molecular Life Sciences, vol. 71, no. 20, pp. 3969–3985, 2014. View at Publisher · View at Google Scholar
  • M. Engeln, P. De Deurwaerdere, Q. Li, E. Bezard, and P.-O. Fernagut, “Widespread Monoaminergic Dysregulation of Both Motor and Non-Motor Circuits in Parkinsonism and Dyskinesia,” Cerebral Cortex, 2014. View at Publisher · View at Google Scholar
  • Yasir Hasan Siddique, Mohammad Faisal, Falaq Naz, Smita Jyoti, and Rahul, “Role of Ocimum sanctum leaf extract on dietary supplementation in the transgenic Drosophila model of Parkinson's disease,” Chinese Journal of Natural Medicines, vol. 12, no. 10, pp. 777–781, 2014. View at Publisher · View at Google Scholar
  • Andreas Meinitzer, Andreas Tomaschitz, Stefan Pilz, Manfred Truber, Gabriele Zechner, Martin Gaksch, Barbara Prietl, Genies Treiber, Michaela Schwarz, and Andreas Baranyi, “Development of a liquid chromatography-mass spectrometry method for the determination of the neurotoxic quinolinic acid in human serum,” Clinica Chimica Acta, vol. 436, pp. 268–272, 2014. View at Publisher · View at Google Scholar
  • Elisabeth Eklund, Johanna Qvist, Lena Sandström, Fanny Viklund, Jan Van Doorn, and Fredrik Karlsson, “Perceived articulatory precision in patients with Parkinson’s disease after deep brain stimulation of subthalamic nucleus and caudal zona incerta,” Clinical Linguistics & Phonetics, pp. 1–17, 2014. View at Publisher · View at Google Scholar
  • Priscila A. Rocha, Gustavo M. Porfírio, Henrique B. Ferraz, and Virginia F.M. Trevisani, “Effects Of External Cues On Gait Parameters Of Parkinson's Disease Patients: A Systematic Review,” Clinical Neurology and Neurosurgery, 2014. View at Publisher · View at Google Scholar
  • Anne Beuter, Jean-Pascal Lefaucheur, and Julien Modolo, “Closed-loop cortical neuromodulation in Parkinson's disease: An alternative to deep brain stimulation?,” Clinical Neurophysiology, vol. 125, no. 5, pp. 874–885, 2014. View at Publisher · View at Google Scholar
  • Qiang Gao, Aaron Leung, Yonghong Yang, Qingchuan Wei, Min Guan, Chengsen Jia, and Chengqi He, “Effects of Tai Chi on balance and fall prevention in Parkinson's disease: a randomized controlled trial,” Clinical Rehabilitation, vol. 28, no. 8, pp. 748–753, 2014. View at Publisher · View at Google Scholar
  • Sylvia Navailles, Giuseppe Di Giovanni, and Philippe De Deurwaerdere, “Predicting Dopaminergic Effects of L-DOPA in the Treatment for Parkinson's Disease,” Cns Neuroscience & Therapeutics, vol. 20, no. 7, pp. 699–701, 2014. View at Publisher · View at Google Scholar
  • Ahmed A. Moustafa, Rakhee Krishna, Michael J. Frank, Abeer M. Eissa, and Doaa H. Hewedi, “Cognitive correlates of psychosis in patients with Parkinson's disease,” Cognitive Neuropsychiatry, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Ashley McGill, Sara Houston, and Raymond Y. W. Lee, “Dance for Parkinson's: A new framework for research on its physical, mental, emotional, and social benefits,” Complementary Therapies in Medicine, vol. 22, no. 3, pp. 426–432, 2014. View at Publisher · View at Google Scholar
  • David S. Goldstein, “Dysautonomia in Parkinson Disease,” Comprehensive Physiology, vol. 4, no. 2, pp. 805–826, 2014. View at Publisher · View at Google Scholar
  • Ardi Roelofs, “A dorsal-pathway account of aphasic language production: The WEAVER++/ARC model,” Cortex, 2014. View at Publisher · View at Google Scholar
  • Nir Giladi, Yael Manor, Ariela Hilel, and Tanya Gurevich, “Interdisciplinary Teamwork for the Treatment of People with Parkinson's Disease and Their Families,” Current Neurology and Neuroscience Reports, vol. 14, no. 11, 2014. View at Publisher · View at Google Scholar
  • Juan C. Giugni, and Michael S. Okun, “Treatment of advanced Parkinson's disease,” Current Opinion in Neurology, vol. 27, no. 4, pp. 450–460, 2014. View at Publisher · View at Google Scholar
  • Sarah Beggiato, Tiziana Antonelli, Maria C. Tomasini, Andrea C. Borelli, Luigi F. Agnati, Sergio Tanganelli, Kjell Fuxe, and Luca Ferraro, “Adenosine A2A-D2 Receptor-Receptor Interactions in Putative Heteromers in the Regulation of the Striato-Pallidal GABA Pathway: Possible Relevance for Parkinson's Disease and its Treatment,” Current Protein & Peptide Science, vol. 15, no. 7, pp. 673–680, 2014. View at Publisher · View at Google Scholar
  • Samantha Holden, “Treatment of Psychosis and Dementia in Parkinson's Disease,” Current Treatment Options in Neurology, vol. 16, no. 3, 2014. View at Publisher · View at Google Scholar
  • Scott J. Kutscher, Siavash Farshidpanah, and Daniel O. Claassen, “Sleep Dysfunction and its Management in Parkinson’s Disease,” Current Treatment Options in Neurology, vol. 16, no. 8, 2014. View at Publisher · View at Google Scholar
  • Danny Bega, Paulina Gonzalez-Latapi, Cindy Zadikoff, and Tanya Simuni, “A Review of the Clinical Evidence for Complementary and Alternative Therapies in Parkinson's Disease,” Current Treatment Options in Neurology, vol. 16, no. 10, 2014. View at Publisher · View at Google Scholar
  • J. J. Sosnoff, M. J. Socie, B. M. Sandroff, S. Balantrapu, Y. Suh, J. H. Pula, and R. W. Motl, “Mobility and cognitive correlates of dual task cost of walking in persons with multiple sclerosis,” Disability and Rehabilitation, vol. 36, no. 3, pp. 205–209, 2014. View at Publisher · View at Google Scholar
  • Mon S. Bryant, Diana H. Rintala, Jyh-Gong Hou, and Elizabeth J. Protas, “Influence of fear of falling on gait and balance in Parkinson’s disease,” Disability and Rehabilitation, vol. 36, no. 9, pp. 744–748, 2014. View at Publisher · View at Google Scholar
  • Stephen A. Buetow, Alison Talmage, Clare McCann, Laura Fogg, and Suzanne Purdy, “Conceptualizing how group singing may enhance quality of life with Parkinson's disease,” Disability and Rehabilitation, vol. 36, no. 5, pp. 430–433, 2014. View at Publisher · View at Google Scholar
  • James E. Frampton, “Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease,” Drugs, 2014. View at Publisher · View at Google Scholar
  • Ju-Young Kim, Su-Hyun An, Yun-Seok Rhee, Chun-Woong Park, and Eun-Seok Park, “A Comparative Study Between Spray-Drying and Fluidized Bed Coating Processes for the Preparation of Pramipexole Controlled-Release Microparticles for Orally Disintegrating Tablets,” Drying Technology, vol. 32, no. 8, pp. 935–945, 2014. View at Publisher · View at Google Scholar
  • Annukka Kallinen, Boyan Todorov, Roope Kallionpaa, Susanne Back, Mirkka Sarparanta, Mad Raki, Juan A. Garcia-Horsman, Kim A. Bergstrom, Erik A. A. Wallen, Pekka T. Mannisto, and Anu J. Airaksinen, “Synthesis and biological evaluation of novel I-123-labeled 4-(4-iodophenyl)butanoyl-L-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo,” European Journal of Medicinal Chemistry, vol. 79, pp. 436–445, 2014. View at Publisher · View at Google Scholar
  • M. Zibetti, A. Merola, C. A. Artusi, L. Rizzi, S. Angrisano, D. Reggio, C. De Angelis, M. Rizzone, and L. Lopiano, “Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience,” European Journal of Neurology, vol. 21, no. 2, pp. 312–318, 2014. View at Publisher · View at Google Scholar
  • H.-C. Wang, C.-C. Lin, C.-I. Lau, A. Chang, F.-C. Sung, and C.-H. Kao, “Risk of accidental injuries amongst Parkinson disease patients,” European Journal of Neurology, vol. 21, no. 6, pp. 907–913, 2014. View at Publisher · View at Google Scholar
  • Karen M. Smith, Susan E. Browne, Srinivasan Jayaraman, Carina J. Bleickardt, Lisa M. Hodge, Edward Lis, David Hill, Eric M. Parker, Robert A. Hodgson, Leon Yao, Sunday L. Rittle, Nathalie Innocent, Deborra E. Mullins, George Boykow, and Ian J. Reynolds, “Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice,” European Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Maria Papathanou, Peter Jenner, Mahmoud Iravani, Michael Jackson, Kim Stockwell, Isabel Strang, Bai-Yun Zeng, Andrew C. McCreary, and Sarah Rose, “The H-3 receptor agonist immepip does not affect L-dopa-induced abnormal involuntary movements in 6-OHDA-lesioned rats,” European Journal of Pharmacology, vol. 741, pp. 304–310, 2014. View at Publisher · View at Google Scholar
  • Todd J. Swick, Joseph H. Friedman, K. Ray Chaudhuri, Erwin Surmann, Babak Boroojerdi, Kimberly Moran, Liesbet Ghys, and Claudia Trenkwalder, “Associations between Severity of Motor Function and Nonmotor Symptoms in Parkinson's Disease: A Post Hoc Analysis of the RECOVER Study,” European Neurology, vol. 71, no. 3-4, pp. 140–147, 2014. View at Publisher · View at Google Scholar
  • Pin Wang, Keqin Xie, Cunfu Wang, and Jianzhong Bi, “Oxidative Stress Induced by Lipid Peroxidation Is Related with Inflammation of Demyelination and Neurodegeneration in Multiple Sclerosis,” European Neurology, vol. 72, no. 3-4, pp. 249–254, 2014. View at Publisher · View at Google Scholar
  • Weidong Pan, Qiudong Wang, Shin Kwak, Yu Song, Baofeng Qin, Mingzhe Wang, and Yoshiharu Yamamoto, “Shen-Zhi-Ling Oral Liquid Improves Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Xiang-Hong Zeng, Qian-Qian Li, Qian Xu, Fang Li, and Cun-Zhi Liu, “Acupuncture Mechanism and Redox Equilibrium,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  • Chao Jiang, Ping Liu, Jingsheng Zhang, Wenjing Bao, Shaobo Qiu, Yan Liang, and Lin Jiang, “Clinical Study of Effects of Jian Ji Ning, a Chinese Herbal Medicine Compound Preparation, in Treating Patients with Myasthenia Gravis via the Regulation of Differential MicroRNAs Expression in Serum,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, pp. 1–14, 2014. View at Publisher · View at Google Scholar
  • C. Elaine Little, and Marjorie Woollacott, “Effect of attentional interference on balance recovery in older adults,” Experimental Brain Research, 2014. View at Publisher · View at Google Scholar
  • Valerie E. Kelly, and Anne Shumway-Cook, “The ability of people with Parkinson's disease to modify dual-task performance in response to instructions during simple and complex walking tasks,” Experimental Brain Research, vol. 232, no. 1, pp. 263–271, 2014. View at Publisher · View at Google Scholar
  • Veronica Munoz-Soriano, Sandra Lopez-Domenech, and Nuria Paricio, “Why mammalian wound-healing researchers may wish to turn to Drosophila as a model,” Experimental Dermatology, vol. 23, no. 8, pp. 538–542, 2014. View at Publisher · View at Google Scholar
  • Vincent A. Jourdain, Nicolas Morin, Marc Morissette, Laurent Gregoire, and Therese Di Paolo, “Subthalamotomy-induced changes in dopamine receptors in parkinsonian monkeys,” Experimental Neurology, vol. 261, pp. 816–825, 2014. View at Publisher · View at Google Scholar
  • Jana K. Boller, Michael T. Barbe, K. Amande M. Pauls, Christiane Reck, Matthias Brand, Franziska Maier, Gereon R. Fink, Lars Timmermann, and Elke Kalbe, “Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson’s disease,” Experimental Neurology, 2014. View at Publisher · View at Google Scholar
  • Hari S Sharma, Preeti Menon, José Vicente Lafuente, Dafin F Muresanu, Z Ryan Tian, Ranjana Patnaik, and Aruna Sharma, “ Development of in vivo drug-induced neurotoxicity models ,” Expert Opinion on Drug Metabolism & Toxicology, vol. 10, no. 12, pp. 1637–1661, 2014. View at Publisher · View at Google Scholar
  • Livia Dezsi, and Laszlo Vecsei, “Clinical implications of irregular ADMET properties with levodopa and other antiparkinson's drugs,” Expert Opinion on Drug Metabolism & Toxicology, vol. 10, no. 3, pp. 409–424, 2014. View at Publisher · View at Google Scholar
  • Michele A Faulkner, “Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson’s disease,” Expert Opinion on Drug Safety, pp. 1–15, 2014. View at Publisher · View at Google Scholar
  • Wolfgang H. Jost, “Unwanted effects and interaction of intrajejunal levodopa/carbidopa administration,” Expert Opinion on Drug Safety, vol. 13, no. 4, pp. 447–458, 2014. View at Publisher · View at Google Scholar